FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17 Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17. August 21, 2022 at 01:36AM

Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.

from Top News and Analysis (pro) https://ift.tt/R5akcE7
via IFTTT Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17. August 21, 2022 at 01:36AM